Trajectories of Clozapine Concentrations in Women Across Menopausal Age
Schizophrenia Bulletin · 2026
DOI: 10.1093/schbul/sbaf186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Schizophrenia Bulletin, 2026. Verfasst von Franciska de Beer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Clinical Neuroscience and Cognition, University Medical Centre Groningen, University of Groningen, 9713 AP Groningen, The Netherlands. Hauptthemen laut MEDLINE: Clozapine, Menopause, Antipsychotic Agents, Psychotic Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Hypothesis During menopause, estrogen levels change dramatically, which may decrease clozapine blood concentrations in women via estrogen’s inhibitory effect on CYP1A2 activity. This reduction could contribute to increased relapse rates seen in older women with psychotic disorders. Study Design Clozapine blood concentration data were retrieved from the University Medical Center Groningen, the Netherlands. A total of 982 patients (720 men, 262 women), aged 40-60, with 17 104 measurements, were included for analyses. Latent class growth analysis (LCGA) assessed clozapine trajectories by sex, while linear mixed-effects models (LMEM) assessed sex differences between trajectory classes. Study Results The optimal LCGA model (7-quantile splines) identified 3 clusters. Most women (n = 157, 60%) showed a decline in clozapine levels from 520 to 400 μg/L between the ages of 40-60. In contrast, most men (n = 392, 54%) had stable levels (mean 460 μg/L). Two other trajectories appeared in both sexes: a mild increase starting at age 45 (men: n = 272, 38%; women: n = 97, 37%) and a marked increase from 40 to 60 (men: n = 56, ~8%; women: n = 8, ~3%). LMEM showed significantly higher levels in women than men with stable trajectories (estimate = 177.03, t = 2.62, P < .01). A significant age-by-sex interaction (estimate = −0.067, t = −2.63, P < .01) suggested these differences varied over time. Conclusions Sex-specific longitudinal trajectories of clozapine concentrations showed declines in 60% of women aged 40-60, while most men remained stable. As decreasing blood levels could increase relapse vulnerability, monitoring clinical efficacy and side effects is warranted during menopause.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Clinical Neuroscience and Cognition, University Medical Centre Groningen, University of Groningen, 9713 AP Groningen, The Netherlands.
- Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, CH 8032 Zurich, Switzerland.
- Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, NY 11004, United States.
- Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, 9713 AV Groningen, The Netherlands.
- Department of Pharmaceutical Analysis, Groningen Research Institute of Pharmacy, University of Groningen, 9700 AD Groningen, The Netherlands.
ORCID-Profile: Iris M H Hamers, Georgios Schoretsanitis, Shiral S Gangadin
Zitieren
APA
de Beer, F., Hamers, I. M. H., Prycka, M., Schoretsanitis, G., Gangadin, S. S., Touw, D. J., & Sommer, I. E. C. (2026). Trajectories of Clozapine Concentrations in Women Across Menopausal Age. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbaf186
Vancouver
de Beer F, Hamers IMH, Prycka M, Schoretsanitis G, Gangadin SS, Touw DJ, et al. Trajectories of Clozapine Concentrations in Women Across Menopausal Age. Schizophrenia Bulletin. 2026. doi:10.1093/schbul/sbaf186
BibTeX
@article{deBeer2026,
author = {de Beer, Franciska and Hamers, Iris M H and Prycka, Michalina and Schoretsanitis, Georgios and Gangadin, Shiral S and Touw, Daan J and Sommer, Iris E C},
title = {Trajectories of Clozapine Concentrations in Women Across Menopausal Age},
journal = {Schizophrenia Bulletin},
year = {2026},
doi = {10.1093/schbul/sbaf186}
}
EUVIMED